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ABSTRACT
The Relationship Between Vitamin D Status of Adult Women and Diet, Sun Exposure,
Skin Reflectance, Body Competition, and Insulin Sensitivity
Marisa M. McAdler
As the prevalence of vitamin D deficiency continues to grow, mounting evidence
supporting its link with chronic disease strengthens suggesting vitamin D’s candidacy in
the prevention and treatment of multiple disease states and their complications. Dietary
guidelines, however, do not take sun exposure into account. The present study sought to
explore the impact of sun exposure on vitamin D status (serum 25(OH)D), and identify
other significant determinants of serum levels which may have the greatest effects on
overall health. Participants (n = 34) were pre-menopausal women aged 18 to 50 years
(mean age 39 ± 6 years), who had their blood drawn at a local pathology lab and a
follow-up appointment at a health assessment lab for the collection of other
measurements. Mean serum 25(OH)D level was 64 ± 18 nmol/L, and mean dietary
vitamin D intake was approximately 327 ± 229 IU/day. Although 82% of participants
were below the RDA guidelines (600 IU/day for females ages 9-50 years) for dietary
vitamin D intake, only 32% had serum 25(OH)D levels < 50 nmol/L (the recommended
level of sufficiency for bone health) reflecting deficiency. While serum 25(OH)D levels
were significantly correlated to dietary vitamin D intake (r = 0.42, p = 0.0139), it is
reasonable to assume that participants obtained adequate vitamin D from sun exposure.
Fasting serum insulin levels were significantly, positively correlated with BMI (r = 0.83,
p < 0.0001), and sun exposure index (Body Surface Area x Minutes of Direct Sunlight)
was significantly, positively correlated with serum 25(OH)D levels (fall weekend SEI: r
= 0.47, p = 0.0059; spring weekend SEI: r = 0.43, p = 0.0135; average weekend SEI: r =
0.43, p = 0.013; and average overall SEI: r = 0.39, p = 0.0247). Reported sun exposure
appeared to be least during winter weekdays and the most during summer weekends.
Regression analysis was used to determine the strongest predictors of serum 25(OH)D
levels, which were found to be sun exposure, dietary vitamin D intake, skin reflectance,
age, BMI, and ethnicity (R2 = 0.58 , p = 0.0031), demonstrating that simple
questionnaires, such as those employed in this study, can help to predict serum 25(OH)D
status and thus be considered in the future treatment of vitamin D deficiency.
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VITAMIN D: A REVIEW OF LITERATURE
Background on Vitamin D
Classifications
Vitamin D is a fat-soluble vitamin and secosteroid. Its primary natural source is derived
from the photolysis of the skin’s 7-dehydrocholesterol (pro-vitamin D3) under the influence of
UV-B light. In this aspect, vitamin D can be considered to be more of a pro-hormone than a
“vitamin” provided by dietary sources (Takiishi et al., 2010).
Vitamin D has two major forms: vitamin D2, or ergocalciferol, and vitamin D3, or
cholecalciferol. They are collectively known as calciferol. Vitamin D2 is obtained from the
ultraviolet irradiation of a yeast sterol, ergosterol, and is naturally occurring in sun-exposed
mushrooms. Contrastingly, vitamin D3 is synthesized from the skin’s cholesterol precursor 7dehydrocholesterol by UV-B light between 290 and 315 nm (MacLaughlin et al., 1982). This
form is also found in fatty fish and commercially available supplements (Holick, 2007).

Production and Absorption
Despite their structural similarity, vitamin D2 and D3 undergo different pathways of
metabolism initially before joining pathways to become fully activated and thus more biologically
available. There are few factors that affect dietary vitamin D2 and D3 absorption, such as food
quality, source, and the gut’s absorption capacity (Holick, 2007). There are multiple factors,
however, that influence the absorption and metabolism of vitamin D3 by impacting subcutaneous
vitamin D synthesis, including solar UV intensity, age, clothing type, and sunscreen (Holick,
1987; Webb et al., 1988; Matsuoka et al., 1992; Matsuoka et al., 1987; Clemens et al., 1982).
And lastly, melanin, the principal pigment present in the skin, has a significant effect on reducing
cholecalciferol synthesis. Consequently, longer periods of sun exposure are required for
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equivalent vitamin D synthesis in people of African ancestry (AA) compared to those of
European ancestry (EA) (Clemens et al., 1982; Holick et al., 1981).

Metabolism and Activation
Following ingestion via dietary sources or through production from sun exposure, both
forms of vitamin D are biologically inert. To become biologically available and thus “activated,”
dietary vitamin D gets incorporated into chylomicrons following ingestion and sun-produced
vitamin D binds to the vitamin D binding protein (DBP) once leaving the skin. Both molecules
then travel via the lymphatic system and subsequently enter circulation (Holick et al., 2011),
where they are first transported to the liver. In the liver, vitamin D is hydroxylated by vitamin D25-hydroxylase (25-OHase), creating 25-hydroxyvitamin D (25(OH)D), alternatively known as
calcidiol (Holick, 2007; DeLuca, 2004). This partially activated form of vitamin D is easily
detected in the blood and is used to determine vitamin D status because it reflects both intake and
production.
Next, the newly created 25(OH)D travels to the kidneys where it is hydroxylated once
more by 25(OH)D-1α-OHase (CYP27B1) to become the most biologically active form of
vitamin D, 1,25(OH)2D, or calcitriol (Holick, 2007; DeLuca, 2004). Up until only recently, this
pathway of activation was believed to be the only method of creating the biologically available
form of vitamin D. It has been found, however, that not only do most cells in the body contain
vitamin D receptors, but that there are also several tissues and cells which possess 1α-OHase
activity to activate inert forms of vitamin D at a local level (Holick, 2007; Moan et al., 2008;
Adams and Hewison, 2010; Liu et al., 2006). The local production of 1,25(OH)2D may be
involved in regulating up to 200 genes (Nagpal et al., 2005) which facilitate many of the
pleiotropic health benefits that have been reported for vitamin D (Holick, 2007a; Holick, 2008;
Holick and Chen, 2008; Holick et al., 2007; Moan et al., 2008; Adams and Hewison, 2010).
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Functions
While vitamin D is most commonly known for its’ role in bone metabolism, it is also
critical for many other biochemical functions. Additionally, most of the enzymes and proteins
essential for the action of vitamin D are also present in numerous tissues unrelated to bone and
calcium metabolism, including those of the immune and cardiovascular system, as well as those
involved in glycemic control, renal function and cognitive performance (Takiishi et al., 2010).
The biologically active form of vitamin D, 1,25(OH)2D, interacts with vitamin D nuclear
receptors, which are present in most tissues and cells in the human body, such as that of the
intestine, kidneys, and heart (Holick, 2007; DeLuca, 2004; Adams and Hewison, 2010).
Additionally, 1,25(OH)2D helps to stimulate intestinal calcium absorption, which contributes to
one of vitamin D’s most critical roles in bone metabolism. Without vitamin D, a mere 10 to 15%
of dietary calcium and 60% of dietary phosphorus would be absorbed (Christakos et al., 2003).
When sufficient plasma levels of vitamin D are present, 1,25(OH)2D enhances calcium and
phosphorus absorption from the intestines by approximately 40 and 80%, respectively (Heaney,
2004). Furthermore, 1,25(OH)2D interacts with the vitamin D receptor in the osteoblast to
mobilize calcium (among other minerals) from the skeleton, and it also stimulates calcium
reabsorption from the kidney’s glomerular filtrate (Holick, 2007; Dusso et al., 2005). Thus, there
are multiple processes involved in increasing and sustaining bone density.
Active vitamin D has a wide spectrum of biological responsibilities, including but not
limited to inhibiting cellular proliferation and inducing terminal differentiation, inhibiting
angiogenesis, stimulating insulin production, inhibiting renin production, and stimulating
macrophage cathelicidin production (Holick, 2007; Adams and Hewison, 2010; Liu et al., 2006;
Bouillon et al., 2008). Furthermore, 1,25(OH)2D can regulate its own destruction by enhancing
the expression of 25-hydroxyvitamin D-24-hydroxylase (CYP24R), which metabolizes both
25(OH)D and 1,25(OH)2D into water soluble compounds which are excreted from the body
(Holick, 2007).
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Sources
Sun Exposure:
The major source of vitamin D for most humans comes from production in the skin from
exposure to sunlight, or more specifically, solar ultraviolet B (UV-B) radiation during the spring,
summer, and fall seasons (Holick et al., 2007; Holick, 2008; Holick and Chen, 2008; Moan et al.,
2008). For those individuals who avoid sunlight exposure, reside in high-latitude areas where
solar intensity is lessened, or have darker skin pigmentation, dietary and/or supplemental vitamin
D becomes critical for maintaining optimal 25(OH)D plasma concentrations (Sun et al., 2011).
Dietary Sources:
Meaningful amounts of vitamin D are present in a limited number of foods including
fatty fish and fortified dairy products (Table 1) (Holick, 2007). In the US and Canada, milk is
fortified with vitamin D, as are some breads, juices, cereals and other dairy products (Holick,
2007). On the other hand, most countries do not fortify milk with vitamin D due to an outbreak
of vitamin D intoxication among young children in the 1950s that resulted in a law forbidding the
fortification of foods with vitamin D (Holick, 2007). Since that time, Sweden and Finland have
reinstated milk fortification due to the growing prevalence of vitamin D deficiency, and many
other European countries have followed suit with cereals, breads, and margarine (Holick, 2007).
Supplemental to food, both vitamin D2 and D3 can be found in isolated capsules (often
prepared with glycerol due to their solubility in fat) and multivitamin preparations containing
anywhere from 400 to 5,000 IU/capsule. American pharmaceutical preparations, which often
contain mega doses, contain only the D2 form and are used to treat deficiency (Holick, 2007).
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Table 1: Dietary Sources of Vitamin D
Food item
Cod liver oil, 1 tablespoon
Salmon (sockeye), cooked, 3 ounces
Mushrooms
Mackerel, cooked, 3 ounces
Tuna fish, canned in water, drained, 3 ounces
Milk, nonfat, reduced fat, and whole, vitamin D-fortified, 1 cup
Orange juice fortified with vitamin D, 1 cup
Yogurt, fortified with 20% of the DV for vitamin D, 6 ounces
Margarine, fortified, 1 tablespoon
Sardines, canned in oil, drained, 2 sardines
Liver, beef, cooked, 3.5 ounces
Ready-to-eat cereal, fortified with 10% of the DV for vitamin D,
1 cup
Egg, 1 whole (vitamin D is found in yolk)
Cheese, Swiss, 1 ounce

IUs per
serving*

Percent DV**

1,360

227

794

132

400

67

388

65

154

26

115-124

19-21

100

17

80

13

60

10

46

8

46

8

40

7

25

4

6

1

Taken from ODS 2010
* An international unit (IU) is an internationally accepted amount of a substance and often used when
standardizing measurements. Note: 40 IU = 1 mcg.
** Daily Value (DV) is associated with the RDA (Recommended Dietary Allowance) and is based on a
2000 kcal/day intake. The DV for vitamin D is 600 IU for adults and children age 4 and older (ODS 2010).
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Food Fortification:
Because natural food sources of vitamin D are limited, vitamin D fortification policies in
North America serve to increase the amount of vitamin D in the diet. Data from the NHANES III
indicate that fortified milk and cereals contribute 63 and 42% of intake in young Caucasian men
and women, respectively, compared to 30 and 40% from supplements (Park et al., 2001). These
findings also suggest that food fortification policies contribute substantially to vitamin D intake,
and although supplemental intake is recommended in North America and by the revised Canada’s
Food Guide for men and women over 50 years (Health Canada, 2009), it is not the major source
of vitamin D in most reports. Enhanced food fortification with vitamin D, in addition to
recommendations for supplement consumption, may help the population’s majority achieve a
more optimal vitamin D status.

Sun Exposure
Dermal Synthesis
The scientific consensus remains that sun exposure offers the greatest and most
bioavailable source of vitamin D. Compared to dietary sources, vitamin D produced in the skin
from sunlight offers a much greater dose without compromising safety (Haddad et al., 1993). For
instance, when a Caucasian wearing a bathing suit is exposed to one erythemal dose of UV-B
radiation which produces a slight coloring of the skin 24 hours following his/her exposure, the
amount of vitamin D synthesized is equivalent to ingesting between 10,000 and 25,000 IU
(Holick and Chen, 2008).
When solar UV-B photons with energies between 290 and 315 nm from sunlight strike
the skin, photolysis of 7-dehydrocholesterol (provitamin D3) to previtamin D3 occurs in the
plasma membrane of skin cells (MacLaughlin, Anderson and Holick, 1982). Approximately 15%
of the initial provitamin D3 concentration becomes previtamin D3 (Holick, 1987), and nearly 50%
of previtamin D3, in its cis,cis isomer form, is thermodynamically unstable and rapidly transforms
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to vitamin D3 within two hours by the rearrangement of its double bonds (Holick, Tian and Allen,
1995). Once vitamin D3 enters the extracellular space, it is attracted to the vitamin D binding
protein (DBP) in the circulation and together they enter the dermal capillary bed (Feldman et al.,
2005). Vitamin D can be continuously synthesized from the skin for three days after a single
exposure to sunlight (Holick et al., 1980).
Loomis (1967) had first speculated that human skin evolved with increased melanin
production in those living near the equator to prevent excessive production of vitamin D3.
However, we now know that previtamin D3 and vitamin D3 can be broken down with further UVB radiation to inert photoproducts (Holick, MacLaughlin and Doppelt, 1981; Webb, DeCosta and
Holick, 1989). This prevents intoxication of vitamin D3 from the sun. Once previtamin D3 is
produced in the skin, it can be converted to vitamin D3 or into biologically inert photoisomers,
lumisterol and tachysterol, upon further UV-B exposure (Holick, MacLaughlin and Doppelt,
1981). Once vitamin D3 is formed, it can either enter circulation or isomerize to at least 3
photoproducts, suprasterol I, suprasterol II, and/or 5,6-trans-vitamin D3 (Webb, DeCosta and
Holick, 1989). Therefore, sunlight can act as a regulator of vitamin D3 production and prevent
against intoxication.

Individual Factors That Influence Production
A variety of factors affect the skin’s ability to synthesize the vitamin, including skin
pigmentation, aging, and sunscreen use (Holick et al., 2007; Matsuoka et al., 1992; Clemens et
al., 1982).
Recent work by Armas et al. (2007) demonstrated a dose-response relationship between
UV-B exposure from an artificial source and vitamin D status depending on the level of skin
pigmentation, as assessed by skin reflectance. While the researchers acknowledged that dietary
intake can be an important contributor to vitamin D status, it was overall and consistently less
significant as a predictor of status than both sun exposure and skin pigmentation. Other studies
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have also shown that vitamin D intake correlates poorly with serum 25(OH)D (Takeuchi et al.,
1995, Thomas et al., 1998). In a study conducted by Hall et al. (2010), sun exposure adjusted for
body surface area (BSA) exposed to the sun and skin reflectance (i.e. skin pigmentation) were the
principal predictors of vitamin D status in participating subjects. Ninety-three percent of
participants (67 of 72) had a low mean serum 25(OH)D2 concentration (<50 nmol/L) for the
mean of three blood draws. When dietary vitamin D intake, UV-B dose and forehead skin
reflectance were examined, 55% of the variance in serum 25(OH)D could be explained.
Consistent with the results of numerous other studies, Hall et al. (2010) found that sun exposure
(adjusted for ambient levels and clothing) had the greatest impact on serum 25(OH)D levels,
followed by skin reflectance and lastly, dietary intake. Positive predictors of serum 25(OH)D
status also included athlete status, oral contraceptive use, and European ancestry, while North
Asian ancestry was a negative predictor of status.
Increased use of sunscreen must also be considered as a participating factor of
insufficient vitamin D status. In fact, sunscreen containing a protection factor (SPF) of 30
reduces the skin’s vitamin D synthesis by more than 95% (Matsuoka et al., 1987), and individuals
with darker skin pigmentation require sun exposure of at least three to five times longer to
synthesize the same amount of vitamin D when compared to an individual with a lighter skin
pigmentation (Clemens et al., 1982, Hintzpeter et al., 2008). Furthermore, very few dietary
sources contain sufficient vitamin D to compensate for inadequate sunlight exposure.
Other studies have shown that additional factors, such as increasing age (MacLaughlin,
1985) and greater BMI (Worstman et al., 2000; Lee et al., 2009), are also associated with lower
serum 25(OH)D and could affect subsequent recommendations of sun exposure and dietary intake
to achieve optimal status.
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Environmental Factors That Influence Production
In addition to numerous personal factors, any alteration of the sun caused by changes in
latitude, season, or even time of day influences the skin’s production of vitamin D (Holick et al.,
2007; Holick and Chen, 2008). For instance, vitamin D3 synthesis in the skin is greatly limited
above and below latitudes of approximately 33 degrees (Holick et al., 2011). Furthermore, sun
exposure intensity significantly varies by season. Webb et al. (1988) reported that a minimum
exposure intensity of 200 J/m2 is needed to initiate cutaneous vitamin D synthesis. The time
needed to achieve 200 J/m2 ranges from nearly a full day in December to less than 20 minutes on
some days in the spring and summer (Hall et al., 2010). Individual sun exposure doses followed
the same seasonal pattern as for exposure intensity, and dietary recommendations may vary
depending upon both individual and seasonal exposure.

Methods for Measuring Sun Exposure
Individual UV-B exposure can be measured in a variety of ways, including by use of
daily sun exposure logs, recall questionnaires, dosimeter badges, and a sun exposure index (SEI).
Participants in a study by Hall et al. (2010) wore polysulphone (PS) dosimeter badges, a material
comprised of a photosensitive polymer that is used an objective way to measure broadband UV-B
exposure. This material is sensitive to the same wavelengths that affect human skin (Kimlin,
Parisi and Wong, 1998). The exposure captured by the badges was quantified and used to
validate daily sun exposure logs that recorded all time outside between 7am and 7pm, as well as a
SEI which incorporated exposed time and body surface area (BSA) exposed. The average sun
exposure logs kept on the same day as the PS badge was worn were significantly correlated (r =
0.94, p < 0.0001), demonstrating the ability of the sun exposure log and SEI to accurately
measure personal UV-B exposure (Hall et al., 2008).
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Recommendations
Recommendations of vitamin D intake required to maintain target serum 25(OH)D
concentrations remain controversial due to the abundant yet inconsistent research. It is also
believed that sun exposure and vitamin D intake could vary by ancestry and risk of deficiency due
to differences in behavior, as well as food habits and supplement use (Hall et al., 2010), all of
which may impact the recommended daily dietary requirements in different groups of people.
Currently, recommendations are only based on age and gender and do not take sun exposure into
account.
In efforts to create clinical guidelines for the evaluation, treatment, and prevention of
vitamin and mineral deficiencies, including that of vitamin D, given the controversy and wide
spectrum of recommendations, the U.S. Institute of Medicine’s Food and Nutrition Board
developed a system of nutrition recommendations called the Dietary Reference Intakes (DRI).
Prior to the most recent update in 2012, the DRIs for vitamin D and calcium were last published
in 1997. This system is employed by both the United States and Canada and is intended for the
general public and health professionals as a means to broaden existing guidelines known as
Recommended Dietary Allowances (RDA’s) (USDA). Prior to the development of a vitamin Dspecific RDA for each age group, insufficient evidence was available to create concrete dietary
guidelines and thus the Food and Nutrition Board had established an Adequate Intake (AI) value.
The AI for vitamin D was based on values known to affect bone health and calcium absorption
devoid of sun exposure. As the awareness about vitamin D deficiency became more widespread
and research questioned the adequacy of the AI level, the Institute of Medicine reexamined these
guidelines. Using a systematic review and two conferences on vitamin D and health, US and
Canadian government researchers found significant and relevant scientific evidence to develop a
new RDA value for each age group (Table 2) (Yetley et al., 2009) with the exception of the 0-12
month age group, which remains an AI due to the lack of sufficient evidence warranting further
modification. All RDA values have been modified from AI values as of January 2012.
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Table 2: Dietary Reference Intakes for Vitamin D
Life Stage Group
**Adequate Intake (AI) *Recommended Daily Allowance (RDA)
Infants
400 IU/day
Insufficient evidence to create RDA.
0-12 months
(previously 200 IU/day)
Children
600 IU/day
1-8 years
(previously AI of 200 IU/day)
Ages 9-50 years
600 IU/day
(previously AI of 200 IU/day)
Ages 51-70 years
600 IU/day
(previously AI of 400 IU/day)
Ages 70+ years
800 IU/day
(previously AI of 600 IU/day)
Pregnant &
600 IU/day
Lactating Women
(previously AI of 400 IU/day)
(14-50 years)
USDA National Agricultural Library: DRI Tables (last updated October 2012)
Note: All dietary reference intakes are created under the assumption of minimal sunlight.
*The RDA is the average daily dietary intake level that is sufficient to meet the nutrient requirements of
nearly all (97-98%) healthy individuals in an age group. It is calculated from an Estimated Average
Requirement (EAR), which specifies the median requirement for vitamin D for each age group.
**An AI is developed when there exists insufficient scientific evidence to establish an EAR. For healthy
breastfed infants, an AI is the mean intake. The AI for other life stage and gender groups is believed to
cover the needs of all healthy individuals in the groups, however it lacks quantity or certainty of data to be
specified with confidence the percentage of individuals covered by this intake.

Individualizing Dietary Recommendations Based on Risk of Deficiency
At present, it is important to note that the USDA’s dietary recommendations do not take
sun exposure into account. As a result of the many variables affecting the amount of vitamin D
produced through UV-B radiation, recommendations should identify sun exposure as a factor in
achieving optimal vitamin D status. For instance, vitamin D intake needed to maintain target
serum 25(OH)D concentrations in individuals with low sun exposure and dark skin pigmentation
is substantially higher than current recommendations (Hall et al., 2010).
As Hall et al. (2010) concluded, a shortcoming of current recommendations for vitamin D
intake is that they are not individualized to reflect the risk of deficiency which can be determined
by level of sun exposure and skin reflectance. To illustrate how recommendations might vary
when these factors are considered, the researchers estimated the amount of additional vitamin D
intake that would be required to achieve and maintain a serum 25(OH)D greater than or equal to
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50 to 75 nmol/L, and found that individuals with low skin reflectance and low sun exposure
would require the highest intakes to reach sufficient levels (Hall et al., 2010). For instance, the
estimated dietary intake of African American (AA) participants with low sun exposure ranged
from 650 to 1700 IU/day of supplemental vitamin D, depending on the season, to meet the 50
nmol/L threshold and 2100-3100 IU/day to meet the 75 nmol/L threshold. The corresponding
values for AA participants with high sun exposure were 0-850 IU/d for the 50 nmol/L threshold
and 1000-2250 IU/d for the 75 nmol/L threshold. On the contrary, European American (EA)
participants with high sun exposure required no additional vitamin D intake to meet the 50
nmol/L threshold, whereas considerable supplemental intake of 1300 IU/day would be needed in
the winter to meet the 75 nmol/L threshold (Hall et al., 2010). However, EA participants with
low sun exposure needed considerable supplemental intake, 850-1100 IU/day, to meet the 50
nmol/L threshold in the winter and spring and year-round intake ranging from 1000 to 2550 IU/d
to meet the 75 nmol/L threshold (Table 3, 4) (Hall et al., 2010).
Table 3: Estimated vitamin D intake needed to achieve serum 25(OH)D 50 nmol/L in
participants with median skin reflectance for African and European ancestries with low
(20th percentile) and high (80th percentile) sun exposure for each season
AA
AA
EA
EA
Cohort
Low sun (IU/day) High sun (IU/day) Low sun (IU/day) High sun (IU/day)
Fall
1050
0
200
0
Winter
1700
850
1100
0
Spring
1500
0
850
0
Summer
650
0
0
0
1
Estimated using regression model to predict serum 25(OH)D based on skin reflectance, sun exposure and
200 IU/d current vitamin D intake, and using expected serum 25(OH)D response to additional vitamin D
supplementation based on a dose- response study using 0.7 nmol/L for every additional 1 mg of vitamin D
intake from supplements (Heaney 2003).
2
Values include the baseline intake of 200 IU/d.
3
40 IU=1 ug.

Hall et al., 2010
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Table 4: Estimated vitamin D intake needed to achieve serum 25(OH)D >75 nmol/L in
participants with median skin reflectance for African and European ancestries with low
(20th percentile) and high (80th percentile) sun exposure for each season
AA
AA
Cohort
Low sun (IU/day) High sun (IU/day)
Fall
2500
1250
Winter
3100
2250
Spring
2900
1400
Summer
2100
1000
1
40 IU = 1 ug
2
Estimated as described in footnote to Table 3

EA
Low sun (IU/day)
1650
2550
2250
1000

EA
High sun (IU/day)
0
1300
50
0

Hall et al., 2010
Contrastingly, a recent study in the southwestern US showed that both sun exposure and
vitamin D intake significantly predicted vitamin D status, however this effect was more
pronounced in Whites than in Blacks or Hispanics (Jacobs et al., 2008). This may be explained
by the fact that EA participants commonly consume higher levels of fortified dairy products and
have higher total vitamin D intake than other ethnic groups (Calvo et al., 2005). Overall and
regardless of ethnicity, this study confirmed that relatively high intakes of vitamin D would be
needed to achieve serum 25(OH)D concentrations of 50 or 75 nmol/L for participants with low
sun exposure, especially during the winter months, suggesting that dietary vitamin D intake
should be customized for those individuals who are at greater risk of deficiency (Calvo et al.,
2005).

Toxicity
Etiology and Symptoms of Hypervitaminosis D
While significant attention has been paid to deficiency, vitamin D toxicity is also
becoming more common due to the rising popularity of supplementation (Wallace et al., 2011).
In particular, calcium plus vitamin D supplements have been recommended for the prevention of
osteoporotic fractures in postmenopausal women (National Osteoporosis Foundation, 2008), and
millions are relying on supplements to improve health, however, increasing the possibility of
toxicity and making it an important clinical issue.
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The Women’s Health Initiative found a 17% increase in the risk of developing kidney
disease when high supplementation of calcium (1,000 mg/day) and vitamin D (400 IU/day) were
taken regularly (Jackson et al., 2006). Vitamin D toxicity, which is identified as serum 25(OH)D
levels consistently greater than 500 nmol/L (>200 ng/ml), can also clinically manifest in the form
of hyperkalemia, hypercalciuria, and retarded growth in infants (Jones, 2008). Additionally, new
evidence is emerging for increased risk of all-cause mortality, cancer, cardiovascular disease,
falls and fractures at elevated exposures (Melamed et al., 2009; Helzlsouer, 2010; Fiscella and
Franks, 2010).
Initial toxicity often manifests itself with non-specific symptoms including anorexia,
weight loss, polyuria, and heart arrhythmias (Institute of Medicine (IOM) Food & Nutrition
Board, 2010). Symptoms may become more severe with worsening toxicity, in part related to
increased serum calcium levels, leading to vascular and tissue calcification with subsequent
damage to the heart, blood vessels, and kidneys (IOM Food & Nutrition Board, 2010).

Upper Level Recommendations
Scientific evidence examining the effect of higher exposures remains extremely limited.
Thus, the safety of long-term, high dose supplementation and elevated serum levels is yet to be
fully and distinctly determined, however, the Food and Nutrition Board (FNB) updated the Upper
Level (UL) for intake based off of the most recent evidence.
While symptoms of toxicity are unlikely at daily average intakes below 10,000 IU/day,
the FNB reviewed emerging evidence from national survey data, observational studies, and
clinical trials finding that even lower levels of vitamin D intakes and serum 25(OH)D levels may
have adverse health effects over time. The FNB concluded that serum 25(OH)D levels above
approximately 125–150 nmol/L (50–60 ng/mL) should be avoided, while even lower serum levels
(approximately 75–120 nmol/L or 30–48 ng/mL) are associated with an increased risk of allcause mortality, cancer, cardiovascular disease, falls and fractures (National Institute of Health,
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2011). The FNB also highlighted research which found that consuming 5,000 IU/day of vitamin
D achieved serum 25(OH)D concentrations between 100–150 nmol/L (40–60 ng/mL). This
committee then applied an uncertainty factor of 20% to this intake value to derive an UL of 4,000
IU for children ages 9 years and older with corresponding lower amounts for younger children
(Table 5) (National Institute of Health, 2011).
Table 5: Upper Level of Vitamin D for Each Age Group
Life Stage Group
Upper Level (UL)*
Infants 0-6 months
1000 IU/day
Infants 6-12 months
1500 IU/day
(previously 1000 IU/day)
Children 1-3 years
2500 IU/day
(previously 2000 IU/day)
Children 4-8 years
3000 IU/day
(previously 2000 IU/day)
Ages 9-50 years
4000 IU/day
(previously 2000 IU/day)
Adults 50+ years
4000 IU/day
(previously 2000 IU/day)
Pregnant & Lactating Women
4000 IU/day
(14-50 years)
(previously 2000 IU/day)
*Note: The Upper Level is the highest level of intake from food and supplements that does not pose a heath
risk.
USDA National Agricultural Library: DRI Tables (last updated October 2012)

Deficiency
Prevalence of Deficiency
Vitamin D insufficiency and deficiency has reached astounding prevalence of up to 63%
and has been identified as a worldwide health issue in recent years (National Institute of Health,
2011). Predominantly the result of suboptimal sun exposure in addition to inadequate dietary
intake, the true “boundaries” of insufficiency and deficiency remain somewhat controversial. At
present, vitamin D deficiency is defined by the Institute of Medicine to be <12 ng/ml (<30
nmol/L), and insufficiency as 12-20 ng/ml (30-50 nmol/L) (National Institute of Health, 2011).
Comparatively, >20 ng/ml (>50 nmol/L) is considered to be adequate for bone and overall health
in healthy individuals.
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In the National Health and Nutrition Examination Survey (NHANES) 2005-2006,
approximately 24% of 1-21 year olds (n = 3136) were found to be vitamin D deficient (<15
ng/ml), and 63% were insufficient (15-29 ng/ml). Similarly, 26% of adults (n = 3454), ages >21
years, were found to be deficient and 60% were insufficient (Sharief et al., 2011). Mean serum
25(OH)D concentrations appear to have decreased over time relative to decreased sun exposure
and milk consumption and an increased prevalence of obesity (Looker et al., 2008). Parallel to
the rising prevalence of deficiency, there also exists an increasing occurrence of multiple
conditions beyond bone health and obesity of which vitamin D is thought to be involved,
including cancer, diabetes, hypertension, and infections (Holick, 2007; Pittas 2010, Pittas et al.,
2007; Forman et al., 2007).

Risk Factors for Deficiency
Undoubtedly, there are some conditions that place individuals at a higher risk for vitamin
D deficiency. These abnormalities include chronic kidney disease, hepatic failure, malabsorption
syndromes (cystic fibrosis, inflammatory bowel disease, Crohn’s disease, bariatric surgery,
radiation enteritis), hyperparathyroidism, certain medications (anti-seizure medications,
glucocorticoids, medications to treat HIV and AIDS, antifungals, cholestyramine); AfricanAmerican and Hispanic ancestry; pregnancy and lactation; older age (>70 years) with a history of
falls and nontraumatic fractures; obesity (BMI >30); granuloma-forming disorders (sarcoidosis,
tuberculosis, histoplasmosis, coccidiomycosis, berylliosis); and some lymphomas (Holick, 2007).
Other factors contributing to deficiency in many otherwise healthy adults are found to
include seasonal effects such as decreased sun exposure, a lack of supplemental and dietary
vitamin D intake, darker skin pigmentation, and living at higher latitudes (Gozdzik et al., 2010).
Obesity:
Serum 25(OH)D levels have been found to be low in obese children and adults (Liel et
al., 1988; Bell et al., 1985; Worstman et al., 2000; Yanoff et al., 2006). While this association
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has yet to be fully understood, the hypothesis has been that there is sequestration of vitamin D in
the subcutaneous body fat reducing the vitamin’s bioavailability (Worstman et al., 2000). This
idea is explored and confirmed by Lagunova et al. (2010), whose results suggested that despite
matched dietary intake and sun exposure, the obese subgroup had significantly lower serum
25(OH)D levels.
Sedentary lifestyles that are often linked to obesity could also be a factor, as they may be
associated with less outdoor activities and thus reduced sunlight (Dewey & Heuberger, 2011).
This indirect factor may further contribute to reduced endogenous vitamin D production
and compromised vitamin D status. Additionally, some studies have shown significant
differences in mean dietary vitamin D intake among obese individuals, suggesting a lower overall
consumption of vitamin D-containing foods when compared with non-obese individuals
(Rajakumar et al., 2008; Rajakumar et al., 2005).
In a study by Rajakumar et al. (2008), researchers found that vitamin D deficiency was
common among obese and non-obese preadolescent (ages 6-10 years) African American children,
and that 400 IU vitamin D3 daily (200 IU below the updated RDA as of January 2012 for this age
group) for one month was inadequate to raise both group’s blood levels of 25(OH)D to a level
greater than 30 ng/ml (Rajakumar et al., 2008). This study also showed that bone metabolism,
bone turnover, and bone mineral content were altered in severe obesity.
Rajakumar et al. (2008) found that the anticipated compensatory increase in parathyroid
hormone (PTH) in response to vitamin D deficiency and insufficiency was observed only among
the non-obese participants, suggesting that the innate PTH response to vitamin D deficiency may
be blunted in the obese state.
Due to the notable potential differences in vitamin D bioavailability and metabolism in
obese individuals, it can be argued that adequacy of vitamin D replacement in hypovitaminosis D
should be dependent upon body mass index (Lee et al., 2009). Overweight and obese patients
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with vitamin D deficiency likely require higher doses of vitamin D to achieve repletion compared
with individuals of normal body weight.
In addition to its link with suboptimal serum 25(OH)D levels, obesity is associated with
insulin resistance and hyperinsulinemia, which have been implicated in the rising incidence of
cardiovascular disease, metabolic syndrome, and type II diabetes mellitus (Osei, 2010). The
current “epidemic” of obesity is likely increasing the frequency and severity of vitamin D
insufficiency and deficiency encountered in clinical practice. Thus, achieving vitamin D
sufficiency in obese patients may improve general well-being and further reduce the risk of
commonly related chronic diseases.

Consequences of Deficiency
Calcemic Effects:
Historically, vitamin D has been well known for its importance in bone health due to its
numerous roles in maintaining calcium and phosphorus homeostasis and promoting bone
mineralization. Vitamin D’s impact on bone integrity is linked to multiple factors. Firstly, the
body corrects suboptimal calcium plasma levels by causing an increase in bone resorption to
quickly normalize calcium status (Pietschman et al., 2010). When plasma levels of vitamin D
become suboptimal, however, there exists an up-regulation of parathyroid hormone with a
potential for the development of secondary hyperparathyroidism which leads to increased bone
turnover and loss (Frost et al., 2010). The resulting “remodeling space” may subsequently
increase fracture risk (Lips, 2001). In an investigation by Frost et al. (2010), they found a
reduced level of bone mineral density at serum 25(OH)D levels below 50 nmol/L (Frost et al.,
2010). At the cellular level, 1,25(OH)2D has been found to interact with its vitamin D receptor in
the osteoblast. This binding facilitates the development of immature monocytes into mature
osteoclasts, which dissolve the bone matrix and mobilize calcium and other minerals from the
skeleton (Holick, 2007; Dusso et al., 2005).
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Vitamin D deficiency also triggers a reduced efficiency in the intestinal absorption of
dietary calcium and phosphorus, thereby resulting in increased parathyroid hormone (PTH)
secretion (Holick, 2007; Heaney, 2004; Holick et al., 2005; Lips et al., 2006). Interestingly, PTH
secretion is inhibited by the active form of vitamin D (Feldman 2005). The form of secondary
hyperparathyroidism that results from deficiency helps to maintain serum calcium in the normal
range at the expense of mobilizing calcium from the skeleton and increasing phosphorus wasting
in the kidneys, a condition known as phosphaturia (Holick, 2007). The PTH-mediated increase in
osteoclastic activity creates local foci of bone fragility and causes a generalized decrease in bone
mineral density (BMD), resulting in osteopenia and osteoporosis. Phosphaturia often leads to a
low-normal or low serum phosphorus level, thereby causing an inadequate calcium-phosphorus
product and eventual demineralization of the skeleton (Holick, 2007; Aaron et al., 1974). In
young children who have insufficient bone mineral content, this defect results in a variety of
skeletal deformities classically known as rickets (Holick, 2006b; Gordon et al., 2008). In adults,
the epiphyseal plates are closer, and there is sufficient mineral in the skeleton to prevent skeletal
deformities so that this mineralization defect, otherwise known as osteomalacia, often goes
undetected. Osteomalacia is characterized by decreased bone mineral density and is associated
with isolated or generalized aches and pains in the bones and muscles (Malabanan et al., 1998a;
Plotnikoff and Quigley, 2003).
Throughout the life cycle, bone is constantly remodeled; a process that results from a
concerted action of osteoclasts and osteoblasts. The process of bone remodeling is regulated by a
significant number of growth factors, cytokines, and hormones (including estrogen and PTH)
(Pietschmann et al., 2010). When this process becomes impaired, metabolic bone diseases
develop.
Studies have shown positive associations between serum levels of vitamin D and bone
mass and an inverse relationship with the risk of osteoporotic fractures (Valimaki et al., 2004).
Moreover, some (Frost et al., 2010; Abrahamsen et al., 2010) but not all studies (Grant et al.,
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2005) show fracture reduction on treatment with vitamin D and calcium. Rickets in children and
osteomalacia or osteoporosis in adults were the first recognized diseases of a vitamin D
deficiency. These conditions will lead to long-term outcomes including bone and muscle pain as
well as a greater fracture risk with increased age (Holick, 2004).

Rickets and Osteomalacia
Rickets, or “soft bones,” is defined by a T-score between -1 and -2.5 (International
Osteoporosis Foundation, 2010) and is the most common consequence of vitamin D deficiency in
children due to its impact on calcium and phosphorus absorption from the diet. It is often
characterized by skeletal deformities including bowed legs, bone tenderness, dental problems, and
muscle weakness (Bueno and Czepielewski, 2008). While rickets was an epidemic in the 19th
century prior to food fortification and increased availability of dietary supplementations, it is still
commonly seen in many developing countries (Bueno and Czepielewski, 2008). This condition
has nearly disappeared in the US due to the fortification of milk (Bueno and Czepielewski, 2008).
The adult form of this disease is termed osteomalacia, which is also most commonly attributed to
vitamin D deficiency. Similar to rickets, the condition is often accompanied by diffuse body
pains, muscle weakness, bone fragility and an increased risk of osteoporotic fractures (Holick,
2006b).

Osteoporosis
Osteoporosis, literally meaning “porous bone,” is defined by a T-score of -2.5 or lower
(International Osteoporosis Founding, 2010) and is distinguished by an imbalance between
osteoblast and osteoclast activity. It is considered to be the most common and severe
manifestation of metabolic bone diseases (Pietschmann et al., 2010). Principally characterized by
compromised bone strength, this skeletal disorder predisposes a person to an increased risk of
fracture. Bone strength primarily reflects the integration of bone density and bone quality. While
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osteoporosis has a strong genetic component (Obermayer-Pietsch, 2006), it can be differentiated
into primary (e.g. lifelong inadequate calcium and vitamin D intake, postmenopausal osteoporosis
or idiopathic osteoporosis in men) and secondary (e.g. glucocorticoid-induced osteoporosis)
forms. Diabetes mellitus (DM) is among the secondary causes of osteoporosis (Hamdy, 2008).
Diabetes and Bone Health:
Diabetes Mellitus (DM) may further increase one’s risk of bone fractures in the setting of
vitamin D deficiency. In a large cross-sectional study by Takiishi et al. (2010), investigators
found that patients with type II DM experienced bone fractures, predominantly hip fractures, at a
significantly increased rate compared to their diabetes-free counterparts (Miazgowski, 2008).
The pathophysiology of decreased bone strength in DM is also multifactorial: insulin deficiency,
insulin resistance, osteoblast insufficiency, vitamin D deficiency, formation of advanced
glycation end-products in bone, and microvascular complications all appear to contribute to its
development (Pietschmann et al., 2010). Increased risk of fractures may also be attributed to
certain pharmaceutical agents used in type II DM, such as thiazolidinediones, as well as a greater
risk of falling as a consequence of hypoglycemia, poor vision, or neuropathy (Pietschmann et al.,
2010).
Non-Calcemic Effects:
In addition to bone abnormalities, vitamin D deficiency may result in a multitude of other
health problems including muscle weakness. In severe cases, affected children often have
difficulty walking and even standing (Gordon et al., 2008; Holick, 2006b), whereas the elderly
may experience progressive sway and more frequent falls (Bischoff-Ferrari et al., 2005; BischoffFerrari et al., 2009) thereby further increasing their risk of bone fracture.
It is clear that low levels of 25(OH)D produce numerous, potentially detrimental
consequences. Among many of the speculated consequences of vitamin D deficiency, decreased
immune function, impaired mental health, and an increased risk of cardiovascular disease have
shown some of the strongest links to inadequate levels of 25(OH)D (Holick, 2007).

21

Cardiovascular Disease
An association between suboptimal serum 25(OH)D concentrations and an increased risk
of cardiovascular disease (CVD) are supported by data from both ecological and prospective
human studies (Giovannucci et al., 2008; Ginde et al., 2009; Wang et al., 2008; Dobnig et al.,
2008; Kilkkinen et al., 2009; Pilz et al., 2008b; Zitterman et al., 2005). Firstly, low levels of the
active form, 1,25(OH)2D, are associated with low HDL-cholesterol levels, while low levels of the
storage form, 25(OH)D, are associated with high levels of total cholesterol, LDL-cholesterol and
triglycerides increasing risk of CVD (Karhapaa et al., 2010).
This relationship may be explained by numerous factors. For instance, a study by Qi Sun
et al. (2011) found that a high total vitamin D intake (from both foods and supplements) was
associated with a decreased risk of CVD in men (Sun et al., 2011). Their data also suggested that
there was a 2.6% reduction in CVD risk for every 2.5 nmol/L increase in 25(OH)D from vitamin
D intake (i.e. 143 IU/d).
This association may be more critical in patients who are enduring additional physiologic
stresses such as dialysis. For instance, a systematic review identified consistent associations
between active vitamin D treatment (either orally or intravenously administered) and a reduced
risk of CVD in patients receiving dialysis who were vitamin D deficient (Wang et al., 2010).
While the exact mechanism of this relationship has yet to be fully understood, several potential
ideas may explain vitamin D’s effect, including its impact on the renin-angiotensin system,
endothelial dysfunction, vascular smooth muscle proliferation, insulin resistance, and systemic
inflammation, all of which support the beneficial effects of vitamin D in the prevention of CVD
(Bassuk and Manson, 2009).
In addition to CVD, vitamin D deficiency may also increase risk for hypertension.
Schmitz et al. (2009) found that severe vitamin D deficiency triggered hypertension in animal
models. Also, mild vitamin D deficiency (mean 14.8 ng/ml) was associated with higher blood
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pressure in Caucasians, Hispanics, and African Americans. Pilz et al. (2008) demonstrated a
clear association between low levels of serum 25(OH)D, as well as of 1,25(OH)2D, with
prevalent myocardial dysfunction, deaths due to heart failure, and sudden cardiac death. In the
Multi-Ethnic Study of Atherosclerosis, low 25(OH)D levels were linked to increased risk for
developing incident coronary artery calcification (de Boer et al., 2009). These effects, among
potentially a number of others, may be related to vitamin D deficiency due to the presence of the
vitamin D receptor (VDR) on various cardiac tissues, including cardiomyocytes (Tishkoff et al.,
2008), vascular smooth muscle cells (Wu-Wong et al., 2007), and endothelial cells (Takiishi et
al., 2010). Since vitamin D affects inflammation as well as cellular proliferation and
differentiation, adequate vitamin D may thereby lower the risk of developing cardiovascular
disease.

Vitamin D and Glucose Metabolism
Diabetes mellitus (DM) is a disorder that results from defects in insulin production,
secretion and sensitivity (Takiishi et al., 2010). Characterized by inappropriate increases in blood
glucose concentrations due to inadequate insulin action in the body, DM can be due to a primary
loss of insulin secretion (as seen in type I DM), or increased insulin resistance rendering insulin
ineffective (as seen in type II DM) (Boucher, 2011). Over time, insulin resistance leads to insulin
insufficiency and eventual, permanent damage of the pancreas’s insulin-producing beta cells
(Boucher, 2011). With more than one million new cases per year of type II DM alone diagnosed
in the United States and a major cause of significant morbidity, prevention of the disease is
critical (Pittas et al., 2009), as the life-long burden imposed on individuals by DM is heavy.
Over time, associations between vitamin D status and DM have been identified. As early
as the 1980s, it was shown that vitamin D deficiency in rodents and rabbits inhibited pancreatic
insulin secretion, indicating that vitamin D is essential for the function of the endocrine pancreas
(Nyomba et al., 1986). Later, the association between vitamin D and diabetes was reinforced by
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the discovery of the vitamin D receptor (VDR) and vitamin D binding protein (DBP) in
pancreatic tissue (more specifically, in the insulin-producing beta cells) and also in various cell
types of the immune system (Palomer et al., 2008). It has since been shown that vitamin D is
essential for normal insulin release in response to glucose for maintenance of glucose tolerance
(Palomer et al., 2008).

Vitamin D and Insulin Secretion
In a study by Osei et al. (2010), serum 25(OH)D was positively associated with insulin
sensitivity and negatively associated with first- and second-phase insulin secretion. More
importantly, subjects with hypovitaminosis D (serum levels <20 ng/ml) had a greater risk of
insulin resistance and metabolic syndrome, implicating the importance of vitamin D status in
glucose hemostasis. It has since been found that vitamin D insufficiency (20-29 ng/ml) and
deficiency (<20 ng/ml) have both direct and indirect effects on insulin secretion and insulin
action. In this regard, there is mounting evidence that supports the association of low vitamin D
with the development of both types I and II DM (Osei, 2010).
Insulin insensitivity and beta-cell secretory defects are critical to the development of
impaired glucose tolerance and type II DM. Although there is a genetic basis for this
endocrinological dysfunction, there are also environmental factors that play a major role in the
development of DM. In addition to low serum 25(OH)D, obesity plays a significant role in the
pathogenesis of glucose intolerance and type II DM (Osei, 2010; Pittas et al., 2009).
As previously discussed, increasing body fat percentage may compromise the body’s
ability to utilize vitamin D due to the body’s storage of 25(OH)D in the adipose tissue, however it
may also impact an individual’s insulin sensitivity. Two other important factors in low serum
25(OH)D levels are race and ethnicity. Consequently, there is higher prevalence of
hypovitaminosis vitamin D in minority populations such as African-Americans and Hispanics,
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who are also at greater risk of insulin resistance, type II DM, obesity and cardiovascular diseases
compared to Caucasians.

Insulin Resistance
Hypovitaminosis D has long been suspected to be a risk factor for insulin resistance.
Vitamin D may have a beneficial effect on insulin action either directly, by stimulating the
expression of insulin receptor and thus enhancing insulin responsiveness for glucose transport
(Maestro et al., 2000), or indirectly via its role in regulating extracellular calcium and ensuring
normal calcium influx through cell membranes and adequate intracellular cytosolic calcium pool
(Pittas et al., 2007a). Calcium is critical for insulin-mediated intracellular processes in insulinresponsive tissues, such as skeletal muscle and adipose tissue (Ojuka, 2004; Wright et al., 2004;
Williams et al., 1990), with a very narrow range of calcium required for optimal insulin-mediated
functions (Draznin et al., 1987). Changes in the body’s calcium levels may thus contribute to
peripheral insulin resistance (Draznin et al., 1989; Segal et al., 1990; Byyny et al., 1992; Ohno et
al., 1993; Zemel, 1998).
Associations between low vitamin D levels and decreased insulin sensitivity have been
reported in numerous cross-sectional studies (Baynes et al., 1997; Chiu et al., 2004; Gedik and
Akalin, 1996; Borissova et al., 2003; Lind et al., 1989; Orwoll et al., 1994; Lind et al., 1995;
Scragg et al., 2004). Some (Chiu et al., 2004; Scragg et al., 2004), but not all (Orwoll et al.,
1994), observational studies have shown an inverse association between vitamin D or calcium
status and insulin resistance. Results from randomized trials on the effect of vitamin D and/or
calcium supplementation on insulin resistance show either no effect (Orwoll et al., 1994;
Ljunghall et al., 1987; Fliser et al., 1997; Barr et al., 2000; Bowen et al., 2005; Thompson et al.,
2005) or improvement (Sanchez et al., 1997; Zemel et al., 2004; Pittas et al., 2007b) in insulin
action with supplementation.
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Sun Exposure and Incidence of Diabetes
Geographic location may also be associated with vitamin D status and DM. For instance,
the incidence of type I DM is greater in countries of northern latitude (Karvonen et al., 2000;
Sloka et al., 2010), while this trend is reversed in the southern hemisphere (Staples et al., 2003).
UV-B irradiation, which follows a north-south gradient, also has protective properties against
immune dysfunction such as that displayed in type I DM (Cantorna and Mahon, 2004). Mohr et
al. (2008) reviewed the type I DM incidence data for children younger than 13 years during 1990
and 1994 in 51 regions worldwide. They found that global incidence rates of type I DM
approached zero in regions providing high UV-B exposure. Furthermore, seasonality of type I
DM onset is well known (Karvonen et al., 1998; Neu et al., 1997). Kahn et al. (2009) reported
that spring births were associated with a greater likelihood of type I DM, which might reflect
insufficient maternal (and thus neonatal) vitamin D levels during critical stages of fetal
development.

Conclusion
As mounting evidence supporting the link between vitamin D and chronic diseases
continues to strengthen, an overall trend is surfacing which reflects an inverse correlation
between levels of 25(OH)D and metabolic dysfunction, whether cardiovascular, immune, bone,
or inflammatory in nature. The overwhelming strength of clinical data and of numerous
observational studies make vitamin D or its analogues strong candidates for the prevention and
treatment of multiple disease states and their complications (Takiishi et al., 2010). In 2010, the
DRI guidelines for vitamin D tripled from 200 IU to 600 IU/day (1-70 years old) from the
original guidelines set in 1997 without a consideration of sun exposure. It is crucial to better
understand the impact of sun exposure on vitamin D status, and identify other significant
determinants of vitamin D status which may have the greatest effects on overall health. To
contribute to this crucial development of research and clinical understanding, the present study
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sought to explore major contributors to vitamin D status (serum 25(OH)D) in adult women would
require consideration when devising and evaluating successful vitamin D therapies.
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MATERIALS AND METHODS
Study Hypotheses and Objectives
This study had four primary hypotheses and related objectives:
Hypothesis 1:
There is a high prevalence of women on the central coast region of California who are
vitamin D deficient. Objectives were to determine the vitamin D status of women living near the
central coast region of CA; and to determine potential contributors of vitamin D deficiency in
women, including ethnicity, skin pigmentation/reflectance and inadequate dietary vitamin D
intake.
Hypothesis 2:
Obesity and percent body fat negatively influence vitamin D status. Objectives were to
examine the vitamin D status in normal weight women versus overweight women versus obese
women; and to measure percent body fat using DXA analysis and determine the relationship with
vitamin D status.
Hypothesis 3:
Blood pressure, waist circumference, fasting insulin and glucose levels, parathyroid
hormone, glycosylated hemoglobin, and age are negatively associated with vitamin D status,
whereas bone density and physical activity are positively associated. Objectives were to measure
blood pressure, waist circumference, fasting insulin and glucose levels, parathyroid hormone, and
glycosylated hemoglobin, and record age, and determine their association with vitamin D status;
and to measure bone density using DXA analysis and determine its relationship with vitamin D
status.
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Hypothesis 4:
Sun exposure is positively correlated with vitamin D status. Objectives were to use a
seasonal questionnaire about typical weekday and weekend sun exposure to capture habitual sun
exposure and relate it back to vitamin D status.

Study Design
A cross-sectional study was conducted to examine the factors that influence vitamin D
status in a group of pre-menopausal women. This study focused on the baseline data of a larger,
intervention-based study, which is not detailed in this paper. Data were gathered on
anthropometric measurements, body composition, biochemical data, sun exposure, physical
activity, dietary calcium and vitamin D intake and skin reflectance (pigmentation) from 34
participants residing along California’s central coast, an area spanning 60 miles from Santa Maria
to Paso Robles capturing a population of approximately 300,000. A rolling enrollment was used
over all four seasons of the year to better capture changes in sun exposure and acquire a sufficient
number of participants for the study. Flyers advertising the study were posted at Cal Poly State
University, emailed to faculty and staff, placed in physician and health clinic offices across San
Luis Obispo County, as well as in the newsletter of a local women’s fitness center. All protocols
and procedures in this study were first approved by the university’s Human Subjects Research
Committee.

Participants
Participants were screened via telephone to determine initial eligibility, which included
18 to 50 years old, non-diabetic, pre-menopausal women. Each prospective participant
completed a uniform medical history and screening questionnaire that included items related to
the inclusion and exclusion criteria and willingness to have specific tests done to determine their
suitability for the study.

29

Exclusion criteria included: <18 years old, >50 years old, BMI <18.5 or >40, selfreported consistent sun-screen use on all or most exposed skin, frequent use of tanning beds, use
of high-dose vitamin supplements (vitamin D > 1,000 IU/day) within the preceding two months,
pregnancy, any disease or underlying condition requiring treatment that may affect vitamin D
absorption or metabolism, use of medications that affect vitamin D metabolism, fat
malabsorption, use of laxatives, liver disease, kidney disease, diabetes, and/or tobacco use within
the past one year.

Lab Assessment at Central Coast Pathology Laboratories
After initial eligibility was determined, participants fasted for 12 hours and reported to a
local clinical lab to provide blood and urine samples. All blood draws and analyses were
performed at a Central Coast Pathology (CCP) Laboratory (www.ccpathology.com). This
company provides services to healthcare professionals as well as university studies and has seven
locations in the area making it convenient for participants to participate.
During this baseline blood draw, measurements included the following: fasting blood
glucose; insulin; glycosylated hemoglobin; parathyroid hormone; and serum 25(OH)D levels.
Serum 25(OH)D was measured by an IDS-iSYS Immunodiagnostic System.
If participants were found to have vitamin D levels less than 20 nmol/L (reflecting
vitamin D deficiency) and/or a fasting blood glucose greater than 126 mg/dL (reflecting a
potential diagnosis of diabetes), they were advised to consult with their personal physician and
they were disqualified from the study.

Nutrition and Health Assessment at Cal Poly
The second appointment was scheduled approximately one to two weeks following the
initial blood draw so that lab results were available. This appointment included an assessment of:
bone density; body composition; blood pressure; anthropometrics; skin reflectance; dietary
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vitamin D and calcium intake; sun exposure; and physical activity level. All measurements were
performed in a private setting and recorded by one of three designated research team members to
achieve maximal consistency. All questionnaires were administered by Registered Dietitians or
trained research staff. Assessments took place at one of two locations: the Nutrition and Health
Assessment Lab at Cal Poly (n = 30) or at the office of Dr. Mary Oates in Santa Maria (n = 4).
Location was dependent upon the participant’s convenience.
Body Composition and Bone Mineral Density:
Full-body Dual Energy X-ray Absorptiometry (DXA) was used to determine body fat
mass, body fat percentages, lean body mass and bone mineral density of each participant. DXA
scans and their analyses were performed using iDXA instruments (Lunar, GE Healthcare) and
enCORE software (Lunar, GE Healthcare). Participants were asked to complete a four-hour fast
and a pregnancy test (to ensure safety) prior to the DXA scan. Standard procedures were used to
complete all DXA scans.
Blood Pressure:
Blood pressure was measured on the left arm of each participant immediately following
the DXA scan to insure a resting state. A Life Source UA-787 Digital Blood Pressure Monitor,
manufactured by A&D Medical, was used on all participants.
Anthropometric Measurements:
Body weight was recorded to the nearest 0.1 kilogram and height to the nearest 0.1
centimeter. Body mass index (BMI) was calculated as weight (kilograms) divided by height
(meters) squared. Waist and hip circumference measurements were recorded to the nearest 0.1
inch for the calculation of waist to hip ratios, which was performed by dividing waist by hip
measurement.
Skin Reflectance (Pigmentation) Assessment:
Skin reflectance was measured with a Minolta 2500d spectrophotometer (Konica Minolta
Sensing). Measurements were taken on the middle upper inner right arm, the dorsum of the right
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hand between the thumb and index finger, and the middle of the forehead. Measurements took
approximately 10 seconds each. A small, dime-sized window on the instrument touched the skin,
flashed like a camera, and measured the light reflected from each participant’s skin. A mean
value for each site was obtained by taking three measurements at a given site and moving the
instrument slightly between each measurement. The measurements were expressed in the value
of lightness (L*) using the Commission International d’Eclairage System. The L* value ranges
from zero to 100, with zero indicating a lack of light reflectance (pure black) and a value of 100
indicating 100% light reflectance (pure white). This value is highly correlated to the Melanin
Index (Matsuoka, 1992) and the L* value of the forehead was used in the multiple linear
regression model because it was previously shown to be more correlated with serum 25(OH)D
than the inner arm and hand measurements (Hall et al., 2010).
Dietary Assessment:
Calcium intake was estimated for each participant using an abbreviated Food Frequency
Questionnaire (FFQ) known as the Calcium/Vitamin D Block Screener (NutritionQuest). The
screener was used to estimate calcium intake in milligrams. The Block screeners have been
validated (Cummings et al., 1987) and are well established, resulting in their use at hundreds of
research centers and universities. To estimate dietary vitamin D intake, a more detailed, vitamin
D-specific FFQ was used, which was previously validated by Dr. Hall (Hall et al., 2010) (see
appendix). This questionnaire inquired about typical, cumulative intake of vitamin D by listing
the food or beverage consumed which contains vitamin D, the participant’s frequency during the
past week (seven days), the past one month (28 days), and the typical serving size consumed each
time. Items included vitamin D supplements and multivitamins, all dairy products, eggs, fish and
seafood, mushrooms, liver, and vitamin D-fortified products including juice, cereals, and breads.
Food models were used to help participants identify typical serving sizes consumed. Cumulative
totals for weekly and monthly intakes allowed for the calculation of the average international
units (IU) per day. Additionally, participants were asked to categorize the frequency of their fish
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intake on a monthly or weekly basis. The amount of vitamin D in the foods/beverages were
determined using values set forth by the United Statues Department of Agriculture Database or
from food labels.
Sun Exposure Assessment:
A seasonal Sun Exposure Recall questionnaire was completed by each subject (see
appendix). This questionnaire examined seasonal exposure by inquiring about the average time
spent outdoors during weekdays and weekends as either less than 30 minutes, 30 to 60 minutes,
60 to 90 minutes, or greater than 90 minutes during the Fall, Winter, Spring and Summer months.
Additionally, the questionnaire inquired about sunscreen usage and typical attire worn for each
season (for both weekdays and weekends) by asking participants to record the parts of their body
exposed to sunlight when outdoors, including: face, neck, shoulders, back and chest, upper arms,
lower arms, hands, upper thighs, lower legs, and feet (Figure 1). This tool was previously
validated by Hall et al. (2008).
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Figure 1: Sun Exposure Clothing Key
The diagram shown was used by participants to document typical attire worn (Hall et al., 2010).

Body surface area (BSA) exposed to the sun was calculated using the participants’ height and
weight (for total BSA) and then adjusted for clothing worn, which was determined using the “rule
of nines” as a basis for calculation, as reflected in Table 6 (Hall et al., 2010). Average sun
exposure for weekday and weekend seasons were then calculated by multiplying the average time
out in the sun within the category (minutes/day) by the body surface area (BSA) exposed to
determine a sun exposure index (SEI) value for each season (Barger-Lux and Heaney, 2002; Hall
et al., 2010).
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Table 6: Body Region and Clothing Type with Corresponding BSA Exposed

Physical Activity Assessment:
Physical activity was assessed using the International Physical Activity Questionnaire
(IPAQ) (see appendix). This questionnaire captures total minutes of exercise per week,
categorized as vigorous, moderate or “walking.” The total physical activity is then summarized
using the IPAQ Short Form instrument to obtain total MET-minutes/week.
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Statistical Methods
The statistical analyses were performed using SAS Version 9.3 (SAS Institute, Cary,
NC). All continuous variables were tested for normality using the Kolmogorov-Smirnov test and
variables which lacked a normal distribution were transformed using Box-Cox transformations.
ANOVAs were used to compare the different variables of interest between the three BMI
categories and the three ethnic groups. Pearson correlations were used to identify the strongest
correlations between variables.
To predict serum 25(OH)D, multiple linear regression was used with variables capturing
sun exposure, vitamin D intake and skin reflectance because they all influence vitamin D status.
Measurements used for sun exposure included SEI values for each season’s weekday and
weekend averages along with an overall average and overall weekday and weekend averages
across all seasons. The dietary measurements for vitamin D intake included average vitamin D as
expressed from a seven-day and 28-day FFQ (IU/day) and an online nutrition block screener. All
measurements were examined in the model, including multiple combinations of variables for sun
exposure and vitamin D intake along with forehead skin reflectance. Only forehead skin
reflectance was used because the arm and hand skin reflectance were not significant predictors in
previous studies (cite). Additionally, multiple covariates were considered including ethnicity,
BMI, and age.
The Best Subset Model was employed to help identify the most significant independent
variables as well as the strongest models. That is, after all data were examined in the model, final
predictor variables and models used were chosen for their overall significance (p-value < 0.05)
and the strength of their R-squared value, thereby signifying independent variables and models
which serve as the best predictors of serum 25(OH)D status.
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RESULTS
Population Characteristics
The study population was comprised of 34 participants with a mean age and standard
deviation of 39 ± 6 years, a mean body mass index (BMI) of 27.9 ± 6 kg/m2, and a mean serum
25(OH)D of 64 ± 18 nmol/L (sufficiency: >50 nmol/L) (Table 7). The prevalence of obesity
(BMI ≥30 kg/m2) and vitamin D insufficiency (<50 nmol/L) in this population was 35% and
32%, respectively. Mean dietary vitamin D intake was approximately 327 ± 229 IU/day (RDA
600 IU/day), and mean dietary calcium intake was approximately 552 ± 275 mg/day (RDA 1000
mg/day) (Table 7).
Sixty-eight percent of this population was Caucasian, 26% were Hispanic, and 6% were
Indian, with an average forehead skin reflectance of 62.6 ± 4.2 L*, a mean total body bone
density of 1.2 ± 0.1 g/cm2 and a mean body fat percentage of 37 ± 8% (Table 7).
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Table 7: Population Characteristics
Variable

Fasting Insulin (uIU/ml)1
Glycosylated Hemoglobin (%)1
1-84 Parathyroid Hormone (pg/mL)1
Fasting Blood Glucose (mg/dl)1
Vitamin D: Monthly FFQ (IU/day)
Calcium: Block Screener (mg/day)
Skin Reflectance of Forehead (L*)
Skin Reflectance of Arm (L*)
Skin Reflectance of Hand (L*)
BMI (kg/m2)
Bone Density (g/cm2)
Fat (%)
Systolic BP (mmHg)

64 ± 18
(26 ± 7 ng/ml)
8±7
5 ± 0.2
25 ± 10
90 ± 7
327 ± 230
552 ± 275
63 ± 4
68 ± 4
62 ± 5
28 ± 6
1 ± 0.1
37 ± 8
115 ± 11

Normal
Ranges
>502
(>20 ng/ml)
5-154
4.8-5.9
10-554
70-105
RDA 6003
RDA 10003
N/A
N/A
N/A
18.5-24.94
N/A
25 – 315
<120

Diastolic BP (mmHg)
Age (years)
Physical Activity (total MET-min/week)

76 ± 8
39 ± 6
2242 ± 1645

<80
N/A
4955

Serum 25(OH)D (nmol/L)1

Mean

1

For serum measures, n= 33; all other measures n= 34
Serum 25(OH)D level considered to mark deficiency by RDA guidelines
3
RDA guidelines for women aged 9 to 50 years old
4
Normal ranges as determined by National Institute of Health
5
Acceptable range by American Council on Exercise
2

Vitamin D Intake
The majority (82%) of participants reported an average dietary vitamin D intake of 327 ±
230 IU/day, which was below the RDA of 600 IU/day. Additionally, serum 25(OH)D levels
significantly correlated to dietary vitamin D intake (r = 0.42, p = 0.0139) (Figure 2).
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Figure 2. Serum 25(OH)D and Dietary Vitamin D Intake

Comparison by Body Mass Index
Participants were divided into three groups, based on BMI, for further comparison:
Normal: BMI 18.5 – 24.9 kg/m2; Overweight: BMI 25.0 – 29.9 kg/m2; and Obese: BMI ≥ 30
kg/m2 (Table 8). Fasting serum insulin was significantly higher in the obese group compared to
the normal weight group (Table 8). There was a positive correlation between fasting insulin
levels and BMI (r = 0.83, p < 0.0001) (Figure 4). Forehead skin reflectance was significantly
higher (meaning, skin pigment was lighter) in the Normal and Overweight groups compared to
the Obese group (p = 0.0122). Total body bone density was significantly lower in the Normal
group compared to the Overweight and Obese groups (p = 0.0204). Systolic blood pressure was
significantly higher in the Obese group than in the Normal and Overweight groups (p = 0.0449).
Percent body fat was significantly higher in the Obese group compared to the normal weight
group as expected (Table 8) and there was a positive correlation between body fat and BMI (r =
0.89, p < 0.0001).
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No significant differences were found between the BMI groups and weekday or weekend
sun exposure or serum 25(OH)D levels (Table 8; Figure 3). Although not significantly different,
the obese group had the lowest average levels of serum 25(OH)D.
Table 8. Characteristics by BMI Group
Variable
Mean BMI
Mean BMI
“Normal”
“Overweight”
(n = 12)
(n = 10)
Serum 25(OH)D
(nmol/L)1
Fasting Insulin
(uIU/ml)1
HgbA1c (%)1
1-84 Parathyroid
Hormone (pg/mL)1
Fasting Blood
Glucose (mg/dl)1
Physical Activity
(total METmin/week)
Dietary Vitamin D
(IU/day)
Dietary Calcium
(mg/day)
Forehead Skin
Reflectance
Age (years)
Systolic BP
(mmHg)
Diastolic BP
(mmHg)
Bone Density
(g/cm2)
Body Fat (%)

Mean BMI
“Obese”
(n = 12)

P value

62 ± 20 a

72 ± 12 a

57 ± 20 a

0.1516

2±2a

7 ± 4b

14 ± 6 c

<0.0001*

5 ± 0.1 a
25 ± 8 a

5 ± 0.2 a
21 ± 9 a

5 ± 0.4 a
27 ± 12 a

0.8067
0.4235

88 ± 7 a

91 ± 6 a

92 ± 7 a

0.3019

2517 ± 1551 a

2344 ± 2058 a

2909 ± 3907 a

0.8825

247 ± 207 a

317 ± 160 a

416 ± 281 a

0.2007

526 ± 275a

636 ± 258 a

505 ± 297 a

0.5200

64 ± 3 a

63 ± 2 a

60 ± 5 b

0.0122*

38 ± 7 a
111 ± 11 a

40 ± 5 a
110 ± 12 a

40 ± 5 a
121 ± 9 b

0.6776
0.0449*

74 ± 9 a

73 ± 7 a

80 ± 8 a

0.0882

1.2 ± 0.08a

1.3 ± 0.06b

1.3 ± 0.2b

0.0204*

28 ± 5 a

38 ± 5 b

44 ± 3 c

<0.0001*

1

n = 9 for blood values only in the Overweight category
* Significance denoted by p-value < 0.05
Note: Values sharing a letter (a, b, c) do not have significantly different means
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Figure 3. Body Mass Index and Serum 25(OH)D
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Note: Red line shows RDA cut-off for vitamin D sufficiency at 50 nmol/L.
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Figure 4. Body Mass Index and Fasting Insulin
*BMI Category 1 = Normal weight; 2 = Overweight; 3 = Obese
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Comparison by Ethnicity
Next, participants were subdivided into groups based on ethnicity for further comparison:
Caucasian; Hispanic; and Indian (Table 9). Skin reflectance was significantly lighter in the
Caucasian and Hispanic groups compared to the Indian group (p = 0.0006). Fasting blood
glucose was significantly lower in the Hispanic group compared to the Indian group (p = 0.0426);
and glycosylated hemoglobin was significantly greater in the Indian group compared to the
Caucasian and Hispanic groups (p = 0.0163). No significant differences were noted between
groups for serum 25(OH)D (Figure 5), although levels were markedly lower in the Indian group.
Additionally, there were no significant differences between groups for dietary vitamin D intake,
sun exposure, blood pressure, BMI, body fat percentage, or any other serum measurements (data
not shown).
Table 9. Characteristics by Ethnicity Group
Variable
Caucasian
Hispanic
n=23
n=9
Serum
25(OH)D
65 ± 18 a
62 ± 19 a
(nmol/L)
Forehead Skin
Reflectance
64 ± 3 a
61 ± 3 a
(L*)
Fasting Blood
Glucose
96 ± 5 ab
87 ± 8 a
(mg/dl)

Indian
n=2

P value
0.3921

47 ± 18 a
0.0006*
54 ± 9

b

0.0426*
98 ± 1 b
0.0163*

HgbA1c (%)

5.4 ± 0.2

a

5.3 ± 0.3 a

5.8 ± 0.1 b

*Significance denoted by p-value < 0.05.
Note: Values sharing a letter (a, b, c) do not have significantly different means
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Figure 5. Serum 25(OH)D and Ethnicity
*Ethnicity Group 1 = Caucasian; 2 = Hispanic; 3 = Indian
Note: Red line shows RDA cut-off for vitamin D sufficiency at 50 nmol/L.

Seasonal Sun Exposure
For average weekday sun exposure in the fall, nearly half (47%) of the participants
reported that they spend 30 to 60 minutes/day outside, whereas half (50%) of participants
decreased their estimated weekday exposure to less than 30 minutes/day during the winter season
(Table 10). Similarly, 35% of participants spent 30 to 60 minutes/day outdoors during weekdays
in the spring season, which was less than the number of participants (41%) who spent 60 to 90
minutes/day outdoors during the summer season. Furthermore, the number of participants who
spent more than 90 minutes/day outdoors during weekdays in the summer more than doubled in
the summer season from previous seasons (from 6% to 15%).
For weekend exposure, most participants (35%) reported that they spent greater than 90
minutes/day outdoors during the fall season, which was only slightly less than the winter season:
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32% estimated that they spent greater than 90 minutes/day and 32% estimated that they spent
only 30 to 60 minutes/day outdoors during weekends (Table 10). This exposure dramatically
increased during the warmer months when the majority of participants reported greater than 90
minutes/day during weekends in the spring (50%) and summer (62%) seasons.
Table 10: Reported Sun Exposure From Study Questionnaire (n = 34)
Season
< 30 min
30 – 60 min
60 – 90 min
Fall
38%
47%
9%
Weekday
Winter
50%
35%
9%
Spring
27%
35%
32%
Summer
12%
32%
41%
Weekend

Fall
Winter
Spring
Summer

12%
18%
6%
6%

24%
32%
24%
3%

29%
18%
29%
29%

> 90 min
6%
6%
6%
15%
35%
32%
50%
62%

Sun Exposure Index (SEI)
Participants’ average SEI (BSA x minutes) was not significantly correlated to vitamin D
status on the fall weekdays, winter weekends nor weekdays, spring weekdays, summer weekends
nor weekdays, and average weekday. Significant correlations were found, however, for serum
25(OH)D and fall weekends (r = 0.47, p = 0.0059) (Figure 6), spring weekends (r = 0.43, p =
0.0135) (Figure 7), average weekend sun exposure (r = 0.43, p = 0.013) (Figure 8), and average
overall sun exposure (r = 0.39, p = 0.0247) (Figure 9).
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Table 11: Sun Exposure and Serum 25(OH)D Levels by Season
Variable
Mean SEI1
Mean 25(OH)D
(nmol/L)
Fall Weekend SEI2
28 ± 21
Fall Weekday SEI
16 ± 17
56 ± 20a
Fall Average SEI
22 ± 18
Winter Weekend SEI3
15 ± 12
Winter Weekday SEI
9±7
68 ± 19a
Winter Average SEI
12 ± 9
Spring Weekend SEI4
44 ± 30
Spring Weekday SEI
27 ± 23
58 ± 16a
Spring Average SEI
36 ± 25
Summer Weekend SEI5
62 ± 29
Summer Weekday SEI
45 ± 25
65 ± 17a
Summer Average SEI
53 ± 26
Weekday Average SEI
25 ± 15
Weekend Average SEI
38 ± 19
Overall Average SEI
31 ± 16
64 ± 18a
1

SEI: Sun Exposure Index
Fall season: n = 6
3
Winter season: n = 15
4
Spring season: n = 5
5
Summer season: n = 7
Note: Values sharing a letter (a, b, c) do not have significantly different means
2
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Figure 6. Serum 25(OH)D and Fall Weekend Sun Exposure
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Figure 7. Serum 25(OH)D and Spring Weekend Sun Exposure
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Figure 8. Serum 25(OH)D and Average Weekend Sun Exposure
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Figure 9. Serum 25(OH)D and Average Sun Exposure

Models Predicting Serum 25(OH)D Status
Individually, average dietary vitamin D intake explained 18% of the variation in serum
25(OH)D (p = 0.0139). When examining sun exposure alone, the average weekday SEI
explained 9% of the variation in serum 25(OH)D (p = 0.0885) while average weekend SEI
explained 18% (p = 0.0130) and the overall SEI explained 15% (p = 0.0247). The strongest
predictor of vitamin D status was the average weekend SEI in the fall season, which explained
22% of the variation in serum 25(OH)D (p = 0.0059) (data not shown).
These different measures of sun exposure were compared in models along with dietary
vitamin D intake and forehead skin reflectance to predict serum 25(OH)D status (Table 12).
When weekday SEI was used in the full model, 29% of the variation in serum 25(OH)D was
explained. When weekend SEI was used in the full model, 31% of the variation in serum
25(OH)D was explained, which was the same percentage when an overall average SEI was used
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in the model (Table 12). And lastly, when the fall weekend SEI was used, 32% of the variation
in serum 25(OH)D was explained.
Table 12: Models Comparing Different Measures of Sun Exposure, Along with Dietary
Vitamin D Intake and Skin Reflectance to Predict 25(OH)D Status
Sun Exposure Models
p-value
R2
Model 1
0.0174*
0.29
1
SEI (Weekday Average)
0.0711
2
Vit D Intake (IU/day)
0.0131*
3
Skin Reflectance (forehead)
0.1371
Model 2
0.0122*
0.31
SEI (Weekend Average)
0.0456*
Vit D Intake (IU/day)
0.0550
Skin Reflectance (forehead)
0.1798
Model 3
0.0116*
0.31
SEI (Overall Average)
0.0428*
Vit D Intake (IU/day)
0.0309*
Skin Reflectance (forehead)
0.1404
Model 4
0.0107*
0.32
SEI (Fall Weekend)
0.0386*
Vit D Intake (IU/day)
0.0951
Skin Reflectance (forehead)
0.2165
* Significant denoted by p-value < 0.05
1
SEI = Sun exposure index (minutes in direct sun x body surface area exposed)
2
Mean dietary vitamin D intake including supplements using 28-day FFQ
3
Mean skin reflectance/pigmentation of forehead in L* (lightness)

Using the strongest individual variables (Model 4, Table 12), the covariates of age, BMI,
and ethnicity were incorporated into the full model and explained 43% of the variation in serum
25(OH)D (Table 13). Furthermore, when the interaction variable (Age x BMI) was added, 58%
of variation in serum 25(OH)D was explained, and the variables age and BMI became significant
in the model (Table 13).
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Table 13: Models Predicting 25(OH)D Status with Covariates
Sun Exposure Models
p-value
Model 1
0.0318*
SEI (Fall Weekend)1
Vit D Intake (IU/day)2
Skin Reflectance (forehead)3
Age (years)
Body Mass Index (kg/m2)
Ethnicity
Model 2
SEI (Fall Weekend)

0.0426*
0.0542
0.4913
0.1789
0.2394
0.3155
0.0031*

1

Vit D Intake (IU/day)

2

Skin Reflectance (forehead)3
Age (years)
BMI (kg/m2)
Ethnicity
Age x BMI (interaction)4

R2
0.43

0.58

0.0219*
0.0250*
0.6055
0.0035*
0.0138*
0.3418
0.0071*

* Significant denoted by p-value < 0.05
1
SEI = Sun exposure index (minutes in direct sun x body surface area exposed)
2
Mean dietary vitamin D intake using 28-day FFQ
3
Mean skin reflectance/pigmentation of forehead in L* (lightness)
4
Interaction variable of [Age (years)] x [BMI (kg/m2)]
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DISCUSSION
The present study found that 82% of participants did not meet the current RDA for
dietary vitamin D intake. In fact, mean dietary vitamin D intake was estimated to be 327 ± 229
IU/day, nearly 300 IU/day below the RDA of 600 IU/day for this age group (1-70 years of age)
(FNIC, 2011). Similarly, mean dietary calcium intake was approximately 552 ± 275 mg/day,
nearly 450 mg/day below the RDA of 1000 mg/day for this age group (19–70 years of age)
(FNIC, 2011). Despite the prevalence of self-reported inadequate dietary intake of vitamin D,
only 32% of participants had insufficient serum 25(OH)D levels below 50 nmol/L. Findings in
the present study were similar to the NHANES national survey data (2005-2006), which reported
that approximately 26% of adults (n = 3454) were found to be deficient using the same cut-off
value of 50 nmol/L (Sharief et al., 2011). It is reasonable to assume that participants in this study
obtained adequate vitamin D not from dietary sources but rather from sun exposure given the
location of this study on the central coast of California (35 degrees North), where the weather is
moderate year-round.
While it is known that low dietary intake and low sun exposure both contribute to vitamin
D deficiency, other studies have shown that additional factors, such as older age due a decreased
concentration of the skin’s provitamin D3 in the skin with greater age (MacLaughlin 1985), and
greater BMI secondary to the sequestration of vitamin D in adipose tissue (Worstman et al., 2000;
Lee et al., 2009), are also associated with lower serum 25(OH)D. This idea was thoroughly
explored and confirmed by Lagunova et al. (2010), whose results suggested that despite matched
dietary intake and sun exposure, the obese subgroup had significantly lower serum 25(OH)D
levels. In the present study, however, there was not a significant difference between serum
25(OH)D levels and increasing age or BMI. Additionally, some research has shown that obese
individuals have lower dietary vitamin D intake and sun exposure secondary to different dietary
habits and sedentary lifestyles (Rajakumar et al., 2008; Rajakumar et al., 2005; Dewey &
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Heuberger, 2011), and yet no significant differences were found between the BMI groups for
dietary vitamin D intake and sun exposure in this study (Table 8). Interestingly, however, bone
density was found to be significantly greater in the normal weight group than in the overweight
and obese groups (p = 0.0204), which could hint of potential differences in behavior.
Comparatively, this association could be consistent with the results of a study by Rajakumar et al.
(2008), which found that bone metabolism, bone turnover, and bone mineral content were altered
in the obese state.
Similar to increasing BMI, elevated body fat percentage may compromise the body’s
ability to utilize vitamin D due to the body’s storage of 25(OH)D in the adipose tissue (Holick
2007). While no significant correlation was found between body fat percentage and serum
25(OH)D levels, there was a significant increase in body fat percentage from the Normal group to
Obese group (Table 8) (p < 0.0001) and 25(OH)D was lower in the obese group, although not
significant. Thus, with a larger study population, body fat percentage would likely be inversely
associated with serum 25(OH)D.
In addition to its link with suboptimal serum 25(OH)D levels, obesity has been shown to
be associated with insulin resistance and hyperinsulinemia, which have been implicated in the
rising incidence of cardiovascular disease, metabolic syndrome, and type II diabetes mellitus
(Osei, 2010). This study showed that fasting serum insulin levels significantly increased from the
Normal to Obese groups (Table 8), thereby reflecting a positive correlation between fasting
insulin levels and BMI (r = 0.83, p < 0.0001) (Figure 4). Although fasting insulin was not
significantly correlated to serum 25(OH)D, there was a negative trend as expected.
Another significant difference found between the BMI groups in the present study was
skin reflectance/pigmentation, which is associated with ethnicity. Specifically, forehead skin
reflectance was found to be significantly greater (meaning, lighter skin pigment) in the Normal
and Overweight groups than the Obese group (p = 0.0122). Since darker skin pigmentation
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reduces vitamin D synthesis by the sun, certain ethnicities (such as those with darker pigmented
skin) are at a greater risk for vitamin D deficiency. As the literature supports, two important
factors in low serum 25(OH)D levels are in fact race and ethnicity (Osei, 2010). Consequently,
there is higher prevalence of hypovitaminosis vitamin D in minority populations such as AfricanAmericans and Hispanics, who are also at greater risk of insulin resistance, type II DM, obesity
and cardiovascular diseases compared to Caucasians. While no significant differences were
noted between ethnic groups for serum 25(OH)D levels, the mean Indian group’s status was
markedly lower (Table 9). Additionally, fasting blood glucose was found to be significantly
lower in the Hispanic group than the Indian group (p = 0.0426), and glycosylated hemoglobin
was significantly lower in both the Caucasian and Hispanic groups than the Indian group (p =
0.0163).
When sun exposure was examined, participants reported that their greatest level of sun
exposure occurred during the weekends of summer, when 62% estimated that they receive >90
minutes/day outdoors in direct sunlight (Table 10). On the contrary, participants’ average SEI
(BSA x minutes) had the strongest and most significant correlation to vitamin D status on fall
weekends (r = 0.47, p = 0.0059) over any other season. Due to the higher heat intensity during
the summer, participants may be more apt to seek shade in summer months than during the fall
season when temperatures are more moderate. Interestingly, while not statistically significant,
mean serum 25(OH)D levels appear to be the greatest in the winter season (68 ± 19 nmol/L) over
any other season. The elevated serum levels seen during winter may likely be tied to a delayed
effect of increased sun exposure during the fall.
As our data supports, numerous studies suggest that sun exposure remains one of the
strongest predictors of serum 25(OH)D status (Hall et al., 2010; Jacobs et al., 2008; Calvo et al.,
2005; Armas et al. 2007). Armas et al. (2007) demonstrated a dose-response relationship
between UV-B exposure from an artificial source and vitamin D status depending on the level of
skin pigmentation, as assessed by skin reflectance. While the researchers acknowledged that
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dietary intake can be an important contributor to vitamin D status, it was less significant as a
predictor of status than both sun exposure and skin pigmentation. In a study conducted by Hall et
al. (2010), sun exposure adjusted for body surface area (BSA) exposed to the sun and skin
reflectance were the principal predictors of vitamin D status in participating subjects. Ninetythree percent of participants (67 of 72) had a low mean serum 25(OH)D2 concentration (<50
nmol/L) for the mean of three blood draws. When dietary vitamin D intake, UV-B dose and
forehead skin reflectance were examined, 55% of the variance in serum 25(OH)D could be
explained. Consistent with the results of numerous other studies, Hall et al. (2010) found that sun
exposure (adjusted for ambient levels and clothing) had the greatest impact on serum 25(OH)D
levels, followed by skin reflectance and lastly, dietary intake.
Similar to the findings of Armas et al. (2007) and Hall et al. (2010), the strongest
individual predictors of vitamin D status in the present study were fall weekend SEI, which
explained 22% of the variation in serum 25(OH)D (p = 0.0059), followed by average dietary
vitamin D intake, which explained 18% of the variation in serum 25(OH)D (p = 0.0139). When
these two variables were collectively examined with forehead skin reflectance to predict serum
25(OH)D, 32% of the variance was explained (p = 0.0107). When the covariates age, BMI,
ethnicity, and the interaction variable (Age x BMI) were incorporated into the model, 58% of
variation in serum 25(OH)D levels were explained, and the variables age and BMI became
significant (0.0031) (Table 13). This final and most noteworthy model had a R-squared value
that was nearly identical (yet slightly greater) to that which was achieved in the study by Hall et
al. (2010), thereby confirming that sun exposure, followed by dietary intake, skin reflectance, age
and BMI are all significant predictors of serum 25(OH)D.
Although sun exposure is an important contributor to serum 25(OH)D status, it is very
difficult to quantify. McCarthy (2008) found that individual-level sun exposure data was more
accurate than environmental measurements of sun exposure because participants’ sunscreen use
and sun behavior practices were more important determinants of status (McCarthy, 2008).
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Collecting data on the individual factors contributing to sun exposure is extremely challenging,
along with environmental influences, and the most effective methods have not yet been
determined. However, Hall et al. (2010) found that daily sun exposure logs assessing time
outside and clothing worn accurately captured sun exposure as compared to the objective measure
of sun exposure, polysulphone (PS) dosimeter badges, used in their study. Hall et al. (2008) also
validated sun exposure recall questionnaires against the daily sun logs and found that they
accurately captured individual-level sun exposure thereby demonstrating the usefulness of simple
tools. The present study employed this previously validated tool (Hall et al., 2008).
The strengths of the present study include the large number of assessment tools
employed. Data were collected on dietary intake, sun exposure, skin reflectance, serum levels of
multiple assays, blood pressure, anthropometrics, and body composition/bone density using DXA
analysis. Participants were recruited continually over all four seasons of the year. This rolling
recruitment allowed for a more comprehensive evaluation of seasonal sun exposure and
corresponding serum 25(OH)D levels to capture fluctuations in sun intensity or time spent
outdoors.
While the amount of information gathered from each participant was maximized, the
overall power of the study was low due to the small sample size. In fact, it is likely that many
more correlations would be significant with a larger study population. Other limitations include
the fairly homogeneous group of participants. To ensure that future results are not impacted by
an insufficient number of participants or the inability to test for interpersonal variability, future
studies should include a larger, more heterogeneous sample. Additionally, it is important to
consider the inherent limitations accompanied by memory-based questionnaires, including the
recall bias often associated with the FFQ used to assess vitamin D intake and sun exposure recall.
Ideally, this study’s data will strengthen the understanding of how to better predict and
employ the most effective tools to improve vitamin D status. For instance, a simple questionnaire
which addresses weekend sun exposure could be used. Although vitamin D is uniquely
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synthesized from exposure to sunlight, there are no current public health recommendations or
guidelines for sun exposure. In the quest to reduce the prevalence of worldwide deficiency,
adequate sun exposure seems to surface as the most economical and reasonable of solutions,
however the risk of skin cancer prevails in this journey to pinpoint appropriate prevention
methods and therapeutic tools when confronting vitamin D deficiency. Thus, a greater argument
can be made for tailoring dietary recommendations to be based upon individual needs versus
grouped by age and gender, and that are ideally customized for those individuals who are at
greater risk of deficiency.
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APPENDIX A: Screening Questionnaire
Name: __________ Where did you hear about the study? _____ Date of birth: ____ Age: ____ Gender: ___
Street Address: ______________________ Apt # ___ City: _________________ State: ____ Zip: ______
2
Phone: __________Email: __________ Height: __ Weight: _ BMI: __(kg/m ) Ethnicity:_________________
QUESTION
YES
No
DECLINE
COMMENT
1. Are you willing to take either a vitamin D supplement or a
Must be YES to participate.
placebo (ie. sugar pill) daily for 6 months?
2. Are you willing to have your ht and wt measured twice?
Must be YES to participate.
3. Are you willing to have your bone mineral density and
Must be YES to participate.
body fat (ie. DEXA scan) measured twice in Santa Maria or
San Luis Obispo?
4. Are you willing to have your skin pigmentation measured
Must be YES to participate.
twice?
5. Are you willing to fill out exercise and diet recall
Must be YES to participate.
questionnaires twice? Are you willing to keep a sun
exposure log throughout the 6 months?
6. Are you willing to have your blood drawn three times to
Must be YES to participate.
determine serum vitamin D, lipids, insulin, glucose and
markers of inflammation?
Have you ever had problems getting your blood drawn?
Record answer.
7. Are you willing to take an oral glucose tolerance test
Must be YES to participate.
three times (each time takes 2 hours)?
8. Are you willing to give a urine sample 5 times?
Must be YES to participate.
9. Have you ever used a tanning bed?
Record answer.
If yes, how often? Have you used one in the past 2
Must be NO for the past two months and
months? Do you plan on using one in the next 6 months?
during the study to participate.
Do you use bronzer (or Spray tans)? Are you willing not to
use them?
Must be NO to using bronzer during study.
10. Do you wear sunscreen every day? Where on your
Record answer.
body?
Must be NO to everywhere/everyday (Face is
ok)
11. Do you have any short-term or long-term health
Please list:
problems? (ie. Diabetes (DM))
Do you have fat malabsorption problems or kidney or liver
Must be NO to DM, malabsorption problems,
problems?
menopause, kidney, and/or liver disease to
Have you started menopause?
participate.
12. Do you take any prescription medications? For how
Please list:
long?
13. Do you regularly take over the counter medications
Record answer.
(allergy, antihistamine, antacids, pain relievers, laxatives?)
If so, how often?
Must be NO to laxatives to participate.
14. Do you smoke or use any tobacco products?
Must be NO to participate. Must have quit
If no, have you quit smoking in the past year?
more than 1 yr ago.
15. Do you currently take any supplements that contain
Record answer.
vitamin D?
Multivitamin/mineral supplement?
Calcium and vitamin D supplement?
Must be NO to high dose vitamin D
Vitamin D supplement? Amount?
supplements (>1,000 IU/day) to participate.
Cod liver oil or cod liver oil capsules? Amount?
16. Are you pregnant? Do you plan on becoming pregnant
Must be NO to participate. You must let us
in the next 6 months?
know if you become pregnant and if you do,
we will ask that you not continue in the study.
17. Medical questions:
When was your last medical exam?
Do you see your doctor regularly?
Do you feel comfortable talking to your doctor about
symptoms you experience?
Would you report to your doctor any unusual symptoms you
may have related to the study?
Completed by:__________ Date:_______ Blood draw appt set up?_________ DXA appt?____________
_______ Qualified _______ Disqualified (DQ)
Reason for DQ:__________________
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APPENDIX B:
Vitamin D Study Form

Study ID #:_________________________

Date:_____________________
 Skin Pigmentation Measurement:
Inner Arm
SCI (L*):

SCI (L*):

SCI (L*):

SCI (L*):

SCI (L*):

SCI (L*):

SCI (L*):

SCI (L*):

SCI (L*):

Hand
Forehead
 Ht:___________
 Wt: __________
 List Medical/Medication Changes:________________________________________
Completed:
 DEXA
 Calcium/Vit D Screener
 Vit D-Specific FFQ
 Physical Activity Screener
 Sun Exposure Questionnaire
 Fasting Blood Draw/OGTT/Urine Sample Collected (Date:_________)

B

APPENDIX C:
Vitamin D Food Frequency Questionnaire
Study ID #: ____________
Date:______________
Food / Beverage

Supplements/multivitamin
s
(Some calcium supps
contain vit D)
Milk
Milk beverages (latte,
mocha, cappuccino, etc.)
Soy milk
Chocolate milk
Homemade Pudding/Flan
Ice cream
Whipped cream /Coolwhip
Yogurt
Cheese (Consider cheese
alone & in mixed dishes,
such as enchiladas, pizza,
casseroles, pasta, etc.)
Butter
Margarine
Eggs
Fish
Salmon
Mackerel
Tuna
Sardines
Catfish
Cod liver oil
(NOT including
omega 3 supplements)
Other
Mushrooms
Liver
Ready-to-eat cereals
Ensure or slim fast
Vit D fortified OJ
Other vit D fortified
food/beverage

Frequency/
# of servings
in the past
week
(past 7 days)

Frequency/
# of servings
in the past
4 weeks
(past 28 days)

Typical
serving
size(s) each
time

Comments

Type:
Brand:
Amt. of vit D:
Type:
Don’t forget about milk in sauces/casseroles.

Brand:
Which one:
Brand/type:
Which one:
Brand:
Note type(s) of cheese:

Excluding egg whites. Don’t forget about
omelets, soufflés, frittatas and quiche.
Don’t forget about sushi/sashimi pieces:

Note any fish oil sup.

Brand:
Type/brand:
Which beverage:

C

APPENDIX D:
Physical Activity Questionnaire
We are interested in finding out about the kinds of physical activities that people do
as part of their everyday lives. The questions will ask you about the time you spent
being physically active in the last 7 days. Please answer each question even if you
do not consider yourself to be an active person. Please think about the activities you
do at work, as part of your house and yard work, to get from place to place, and in
your spare time for recreation, exercise or sport.
Think about all the vigorous activities that you did in the last 7 days. Vigorous
physical activities refer to activities that take hard physical effort and make you
breathe much harder than normal. Think only about those physical activities that you
did for at least 10 minutes at a time.
1.
During the last 7 days, on how many days did you do vigorous physical
activities like heavy lifting, digging, aerobics, or fast bicycling?
_____ days per week
No vigorous physical activities: Skip to question 3
2.
How much time did you usually spend doing vigorous physical activities on
one of those days?
_____ hours per day
_____ minutes per day
Don’t know/Not sure
Think about all the moderate activities that you did in the last 7 days. Moderate
activities refer to activities that take moderate physical effort and make you breathe
somewhat harder than normal. Think only about those physical activities that you did
for at least 10 minutes at a time.
3.
During the last 7 days, on how many days did you do moderate physical
activities like carrying light loads, bicycling at a regular pace, or doubles tennis? Do
not include walking.
_____ days per week
No moderate physical activities: Skip to question 5
4.
How much time did you usually spend doing moderate physical activities on
one of those days?
_____ hours per day
_____ minutes per day
Don’t know/Not sure
Think about the time you spent walking in the last 7 days. This includes at work
and at home, walking to travel from place to place, and any other walking that you
might do solely for recreation, sport, exercise, or leisure.

D

5.
During the last 7 days, on how many days did you walk for at least 10 minutes
at a time?
_____ days per week
No walking:
Skip to question 7
6.
How much time did you usually spend walking on one of those days?
_____ hours per day
_____ minutes per day Don’t know/Not sure
The last question is about the time you spent sitting on weekdays during the last 7
days. Include time spent at work, at home, while doing course work and during
leisure time. This may include time spent sitting at a desk, visiting friends, reading, or
sitting or lying down to watch television.
7. Duringthelast7days,how much time did you spend sitting on a weekday?
_____ hours per day
_____ minutes per day Don’t know/Not sure

This is the end of the questionnaire, thank you for participating.
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APPENDIX E:
Sun Exposure Questionnaire
ID#:_______________
Date:__________
In your opinion, is your typical sun exposure “low” or “high” ?
 Low
 High
How would you characterize your skin type with regard to risk of sunburn?
 Always burn, never tan
 Burn slightly, then tan slightly
 Rarely burn, then tan moderately
 Never burn, tan darkly
During the Fall (Sept, Oct, Nov):
How much time do you typically spend outdoors per day on weekdays?
 <30 min
 30-60 min
 60-90 min
 >90 min
How much time do you typically spend outdoors per day on weekends?
 <30 min
 30-60 min
 60-90 min
 >90 min
Using the clothing key, what do you typically wear? (use numbers)
A  B C D E
Using the clothing key, where do you typically put sunscreen? (check box(es))
A  B C D E
SPF:_______
During the Winter (Dec, Jan, Feb):
How much time do you typically spend outdoors per day on weekdays?
 <30 min
 30-60 min
 60-90 min
 >90 min
How much time do you typically spend outdoors per day on weekends?
 <30 min
 30-60 min
 60-90 min
 >90 min
Using the clothing key, what do you typically wear? (use numbers)
A  B C D E
Using the clothing key, where do you typically put sunscreen? (check box(es))
A  B C D E
E

SPF:_______
During the Spring (March, April, May):
How much time do you typically spend outdoors per day on weekdays?
 <30 min
 30-60 min
 60-90 min
 >90 min
How much time do you typically spend outdoors per day on weekends?
 <30 min
 30-60 min
 60-90 min
 >90 min
Using the clothing key, what do you typically wear? (use numbers)
A  B C D E
Using the clothing key, where do you typically put sunscreen? (check box(es))
A  B C D E
SPF:_______

During the Summer (June, July, Aug):
How much time do you typically spend outdoors per day on weekdays?
 <30 min
 30-60 min
 60-90 min
 >90 min
How much time do you typically spend outdoors per day on weekends?
 <30 min
 30-60 min
 60-90 min
 >90 min
Using the clothing key, what do you typically wear? (use numbers)
A  B C D E
Using the clothing key, where do you typically put sunscreen? (check box(es))
A  B C D E
SPF:_______

E

APPENDIX F:
Sun Exposure Clothing Key
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